AXON provides telehealth adult ADHD evaluations, pairing an FDA-cleared objective attention test with clinician-led diagnosis and accommodation documentation.
Adults who suspect ADHD often face long waits and hard-to-reach neuropsychology evaluations, so AXON sells a direct-to-consumer telehealth evaluation to self-referring adults and to universities and primary-care partners that distribute screenings. The evaluation moves from an initial behavioral-health screening into a bundled assessment that combines an FDA-cleared objective attention test with validated rating scales and a structured clinician interview, ending in a written report and care coordination across most US states.
AXON differs from questionnaire-only services such as ADHD Online and from general telehealth prescribers like Talkiatry, Circle Medical, and Klarity by embedding an objective test in every evaluation and stopping short of prescribing. It extends each diagnosis into ADA and Section 504 accommodation documentation and advocacy, and partners with universities and primary-care providers to reach adults who have never been assessed.
